UPDATED Apr 18, 2024
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
EBS | US$1.86 | -15.1% | -81.9% | US$97.4m | US$5.00 | PB0.2x | E148.6% | n/a | ||
ASRT | US$0.75 | -14.5% | -87.4% | US$71.6m | US$3.00 | PB0.5x | E144.9% | n/a | ||
LFCR | US$6.32 | 2.4% | 60.7% | US$192.9m | US$6.00 | PS1.9x | E138.1% | n/a | ||
SNDL | US$1.83 | -12.4% | 24.5% | US$481.4m | US$3.61 | PB0.5x | E135.8% | n/a | ||
SBFM | US$3.32 | -61.9% | -95.1% | US$3.3m | US$300.00 | PB0.2x | E134.4% | n/a | ||
MRVI | US$7.61 | -11.4% | -46.0% | US$1.9b | US$9.78 | PS3.5x | E126.7% | n/a | ||
NBY | US$0.084 | -6.3% | -94.5% | US$2.5m | US$2.60 | PB1.9x | E125.2% | n/a | ||
BHC | US$8.60 | -4.1% | 11.8% | US$3.2b | US$10.33 | PE-5.3x | E123.3% | n/a | ||
VCYT | US$19.20 | -7.4% | -15.5% | US$1.4b | US$30.83 | PS4x | E115.2% | n/a | ||
MLAB | US$99.62 | -4.9% | -41.3% | US$537.4m | US$130.00 | PE566.8x | E108.3% | 0.6% | ||
YCBD | US$1.00 | -2.0% | -80.9% | US$3.0m | US$2.00 | PB0.4x | E107.1% | n/a | ||
SAVA | US$21.19 | -18.8% | -9.3% | US$916.4m | US$124.00 | PB6.7x | E104.9% | n/a | ||
AMRX | US$5.36 | -5.8% | 228.8% | US$1.7b | US$7.31 | PB83.6x | E104.9% | 0% | ||
EVOK | US$0.48 | -11.3% | -77.6% | US$4.1m | US$7.00 | PE-0.5x | E101.6% | n/a | ||
HBIO | US$3.97 | -8.6% | -18.0% | US$172.4m | US$7.00 | PS1.5x | E98.9% | n/a | ||
AYTU | US$2.79 | -10.6% | 4.5% | US$15.5m | US$8.00 | PB0.5x | E96.6% | n/a | ||
PLX | US$1.13 | -7.4% | -51.5% | US$82.5m | US$13.00 | PE9.9x | E96.5% | n/a | ||
ALVO | US$12.89 | 8.8% | 29.5% | US$3.6b | US$16.50 | PS38.6x | E95.2% | n/a | ||
CDXC | US$3.79 | -7.3% | 166.9% | US$286.1m | US$6.08 | PS3.4x | E93.2% | n/a | ||
CTLT | US$55.80 | -2.0% | 25.7% | US$10.1b | US$63.50 | PS2.5x | E92.3% | n/a | ||
CTKB | US$5.96 | -5.4% | -37.5% | US$779.7m | US$10.00 | PS4x | E92.1% | n/a | ||
ELAN | US$13.57 | -8.0% | 39.5% | US$6.7b | US$17.24 | PS1.5x | E91.3% | n/a | ||
ANIK | US$25.43 | -0.7% | -6.6% | US$372.9m | US$30.33 | PS2.2x | E89.1% | n/a | ||
NVAX | US$3.89 | -9.5% | -52.7% | US$544.4m | US$15.40 | PE-1x | E88.9% | n/a |